Ravetch; Jeffrey V.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ravetch; Jeffrey V..The latest application filed is for "antibodies and methods for treatment of viral infections".
Company Profile
20.28.46
- Ravetch; Jeffrey V. - New York NY
- - New York NY US
Patent Activity
| Patent | Date |
|---|---|
| Antibodies And Methods For Treatment Of Viral Infections App 20220298230 - Ravetch; Jeffrey V. ; et al. | 2022-09-22 |
| Immune Complex App 20210228706 - Ravetch; Jeffrey V. ; et al. | 2021-07-29 |
| Antibodies To Cd40 With Enhanced Agonist Activity App 20210139598 - Ravetch; Jeffrey V. ; et al. | 2021-05-13 |
| Anti-inflammatory Polypeptides App 20210130472 - Ravetch; Jeffrey V. ; et al. | 2021-05-06 |
| Immune complex Grant 10,973,904 - Ravetch , et al. April 13, 2 | 2021-04-13 |
| Anti-inflammatory Polypeptides App 20210101986 - Ravetch; Jeffrey V. ; et al. | 2021-04-08 |
| Antibodies to CD40 with enhanced agonist activity Grant 10,894,835 - Ravetch , et al. January 19, 2 | 2021-01-19 |
| Anti-inflammatory polypeptides Grant 10,894,832 - Ravetch , et al. January 19, 2 | 2021-01-19 |
| Anti-tumor agents and methods of use Grant 10,882,917 - Karlsson , et al. January 5, 2 | 2021-01-05 |
| Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods App 20200385443 - Ravetch; Jeffrey V. ; et al. | 2020-12-10 |
| Anti-inflammatory polypeptides Grant 10,851,167 - Ravetch , et al. December 1, 2 | 2020-12-01 |
| Anti-inflammatory polypeptides Grant 10,844,125 - Ravetch , et al. November 24, 2 | 2020-11-24 |
| Antibodies To Cd40 With Enhanced Agonist Activity App 20200071412 - Ravetch; Jeffrey V. ; et al. | 2020-03-05 |
| Antibodies to CD40 with enhanced agonist activity Grant 10,479,838 - Ravetch , et al. Nov | 2019-11-19 |
| Immune Complex App 20190307878 - Ravetch; Jeffrey V. ; et al. | 2019-10-10 |
| HUMAN IgG Fc DOMAIN VARIANTS WITH IMPROVED EFFECTOR FUNCTION App 20190300621 - Ravetch; Jeffrey V. ; et al. | 2019-10-03 |
| Immune complex Grant 10,300,127 - Ravetch , et al. | 2019-05-28 |
| Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods App 20190031738 - Ravetch; Jeffrey V. ; et al. | 2019-01-31 |
| Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods Grant 10,167,332 - Ravetch , et al. J | 2019-01-01 |
| Anti-Inflammatory Polypeptides App 20180179284 - Ravetch; Jeffrey V. ; et al. | 2018-06-28 |
| Anti-Tumor Agents and Methods of Use App 20180171021 - KARLSSON; Mikael ; et al. | 2018-06-21 |
| Immune Complex App 20180117139 - Ravetch; Jeffrey V. ; et al. | 2018-05-03 |
| Anti-Inflammatory Polypeptides App 20180051087 - Ravetch; Jeffrey V. ; et al. | 2018-02-22 |
| Anti-inflammatory polypeptides Grant 9,845,358 - Ravetch , et al. December 19, 2 | 2017-12-19 |
| Antibodies To Cd40 With Enhanced Agonist Activity App 20170253659 - Ravetch; Jeffrey V. ; et al. | 2017-09-07 |
| Modulating Agonistic TNFR Antibodies App 20170247463 - Ravetch; Jeffrey V. ; et al. | 2017-08-31 |
| Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods App 20170218050 - Ravetch; Jeffrey V. ; et al. | 2017-08-03 |
| FC mutants Grant 9,657,101 - Ravetch , et al. May 23, 2 | 2017-05-23 |
| Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods App 20170088608 - Ravetch; Jeffrey V. ; et al. | 2017-03-30 |
| Non-sialylated anti-inflammatory polypeptides Grant 9,587,025 - Ravetch , et al. March 7, 2 | 2017-03-07 |
| Antibodies To Cd40 With Enhanced Agonist Activity App 20160376371 - Ravetch; Jeffrey V. ; et al. | 2016-12-29 |
| Antibodies Specific For The Protofibril Form Of Beta-amyloid Protein App 20160319006 - Ravetch; Jeffrey V. ; et al. | 2016-11-03 |
| Anti-inflammatory Polypeptides App 20160319024 - Ravetch; Jeffrey V. ; et al. | 2016-11-03 |
| Anitbodies specific for the protofibril form of beta-amyloid protein Grant 9,340,607 - Ravetch , et al. May 17, 2 | 2016-05-17 |
| Anti-inflammatory Polypeptides App 20150376280 - Ravetch; Jeffrey V. | 2015-12-31 |
| Methods of identifying anti-inflammatory compounds Grant 9,134,310 - Ravetch , et al. September 15, 2 | 2015-09-15 |
| Non-sialylated Anti-inflammatory Polypeptides App 20140377280 - Ravetch; Jeffrey V. ; et al. | 2014-12-25 |
| Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods App 20140323696 - Ravetch; Jeffrey V. ; et al. | 2014-10-30 |
| Fc Mutants App 20140093959 - Ravetch; Jeffrey V. ; et al. | 2014-04-03 |
| Modulating Agonistic Tnfr Antibodies App 20140010812 - Ravetch; Jeffrey V. ; et al. | 2014-01-09 |
| Fc mutants Grant 08618251 - | 2013-12-31 |
| Fc mutants Grant 8,618,251 - Ravetch , et al. December 31, 2 | 2013-12-31 |
| Anitbodies Specific For The Protofibril Form Of Beta-amyloid Protein App 20130315917 - Ravetch; Jeffrey V. ; et al. | 2013-11-28 |
| Polypeptides With Enhanced Anti-inflammatory And Decreased Cytotoxic Properties And Relating Methods App 20130273040 - Ravetch; Jeffrey V. ; et al. | 2013-10-17 |
| Antibodies specific for the protofibril form of beta-amyloid protein Grant 8,470,321 - Ravetch , et al. June 25, 2 | 2013-06-25 |
| Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods Grant 8,470,318 - Ravetch , et al. June 25, 2 | 2013-06-25 |
| Methods Of Identifying Anti-inflammatory Compounds App 20120190619 - Ravetch; Jeffrey V. ; et al. | 2012-07-26 |
| Polypeptides With Enhanced Anti-inflammatory And Decreased Cytotoxic Properties And Relating Methods App 20120134988 - Ravetch; Jeffrey V. ; et al. | 2012-05-31 |
| Polypeptides With Enhanced Anti-inflammatory And Decreased Cytotoxic Properties And Relating Methods App 20110150867 - Ravetch; Jeffrey V. ; et al. | 2011-06-23 |
| Methods Of Identifying Anti-inflammatory Compounds App 20110076277 - Ravetch; Jeffrey V. ; et al. | 2011-03-31 |
| Method Of Enhancement Of Cytotoxicity In Antibody Mediated Immune Responses App 20110052584 - Ravetch; Jeffrey V. | 2011-03-03 |
| Methods of identifying anti-inflammatory compounds Grant 7,846,744 - Ravetch , et al. December 7, 2 | 2010-12-07 |
| Polypeptides With Enhanced Anti-inflammatory And Decreased Cytotoxic Properties And Relating Methods App 20100278808 - Ravetch; Jeffrey V. ; et al. | 2010-11-04 |
| Antibodies Specific For The Protofibril Form Of Beta-amyloid Protein App 20100209422 - Ravetch; Jeffrey V. ; et al. | 2010-08-19 |
| Polypeptides With Enhanced Anti-inflammatory And Decreased Cytotoxic Properties And Relating Methods App 20100189714 - Ravetch; Jeffrey V. ; et al. | 2010-07-29 |
| Methods Of Identifying Anti-inflammatory Compounds App 20090263378 - Ravetch; Jeffrey V. ; et al. | 2009-10-22 |
| Enhancement Of Antibody-mediated Immune Responses App 20090060911 - Ravetch; Jeffrey V. | 2009-03-05 |
| Polypeptides With Enhanced Anti-inflammatory And Decreased Cytotoxic Properties And Relating Methods App 20090004179 - Ravetch; Jeffrey V. ; et al. | 2009-01-01 |
| Reagents, Methods and Systems for Selecting a Cytotoxic Antibody or Variant Thereof App 20080286819 - Ravetch; Jeffrey V. ; et al. | 2008-11-20 |
| Polypeptides With Enhanced Anti-inflammatory And Decreased Cytotoxic Properties And Relating Methods App 20080206246 - Ravetch; Jeffrey V. ; et al. | 2008-08-28 |
| Enhancement of antibody-mediated immune responses Grant 7,416,726 - Ravetch August 26, 2 | 2008-08-26 |
| Compositions and methods for enhanced dendritic cell maturation and function App 20070014795 - Dhodapkar; Madhav V. ; et al. | 2007-01-18 |
| DNA encoding Fc.gamma.R receptor protein on NK cells Grant 7,038,031 - Ravetch , et al. May 2, 2 | 2006-05-02 |
| Animal model and methods for its use in the selection of cytotoxic antibodies Grant 6,676,927 - Ravetch January 13, 2 | 2004-01-13 |
| Enhancement of antibody-mediated immune responses App 20010036459 - Ravetch, Jeffrey V. | 2001-11-01 |
| Mice mutant for functional Fc receptors and method of treating autoimmune diseases Grant 5,877,396 - Ravetch , et al. March 2, 1 | 1999-03-02 |
Company Registrations
| SEC | 0001612051 | Ravetch Jeffrey V. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 